Skip to main content
. 2020 Jan 18;10(1):1–14. doi: 10.5500/wjt.v10.i1.1

Table 2.

Other major therapeutic additives in models of ex vivo liver machine perfusion

Ref. Ex vivo perfusion type Therapeutic Problem Animal Model Sample size Ex vivo perfusion time (h) Outcomes
Goldaracena et al[9], 2016 SNMP Anti-inflammatory agents IRI Pig Transplantation 5 4 During EVLP: lower AST, TNF-α, IL-6
Lower HA levels, β-galactosidase and higher IL-10 (nonsignificant)
After transplantation: Lower bilirubin, lower IL-6, lower cleaved caspase 3 staining, intact sinusoidal endothelial cell lining
(Alprostadil, n-acetylcysteine, carbon monoxide, sevoflurane)
Lower AST, TNF-α, HA,
ALP and higher IL-10 (nonsignificant)
Rigo et al[65], 2018 NMP HLSC-EV IRI Rat EVLP 9 4 HLSC-EV uptake in treated livers
Reduced necrosis and apoptosis on histology, lower Suzuki tissue injury score, lower apoptosis, lower AST and LDH, lower HIF-1α & TGF-β1 (hypoxia induced markers)
NMP had low hematocrit to induce hypoxia
Beal et al[66], 2019 NMP Enkephalin IRI Rat EVLP 6 4 10 μmol/L determined to be optimal concentration in an in vitro model: Lower ALT and MDA; better preservation of structural architecture; decreased caspase-3 expression;
(δ-opioid agonist)
decreased TUNEL staining; decreased phosphorylation of p38 and JNK; increased expression of p-Akt, PI3K, p-Bad and Bcl-2
Yu et al[67], 2019 HMP NLRP3 Inflammasome IRI Pig Transplantation 6 2 All reduced in HMP-postop group with added mcc950 in perfusate and IV administration of mcc950
After transplantation: TNF-α, IL-1β, β-galactosidase, post-reperfusion serum ALT and AST, MDA, apoptosis staining, caspase-1 levels
Inhibitor mcc950

SNMP: Subnormothermic machine perfusion; NMP: Normothermic machine perfusion; HMP: Hypothermic machine perfusion; IRI: Ischemia-reperfusion injury; EVLP: Ex vivo liver perfusion; AST: Aspartate aminotransferase; HA: Hyaluronic acid; ALP: Alkaline phosphatase; HLSC-EV: Human liver stem cells-derived extracellular vesicles; LDH: Lactate dehydrogenase; ALT: Alanine aminotransferase; MDA: Malondialdehyde; IV: Intravenous.